Updates in the management of inflammatory bowel disease during pregnancy
Authors:
- 24 March 2019
- journal article
- review article
- Published by AMPCo in Medical Journal of Australia
- Vol. 210 (6) , 276-280
Abstract
The best pregnancy outcomes for women with inflammatory bowel disease (IBD) occur when their disease is in remission at conception and remains in remission throughout pregnancy. Active IBD can lead to adverse pregnancy outcomes, including spontaneous abortion, pre‐term birth and low birthweight. The majority of women with IBD who are taking maintenance medication will require medication throughout the pregnancy to prevent disease relapse. Most IBD medications are considered safe in pregnancy and breastfeeding, except for methotrexate. Pre‐conception counselling should be arranged with the patient's IBD specialist and should include discussions regarding the importance of optimising disease control before and during pregnancy as well as the medication management plan for pregnancy. Patients with IBD should be reassured that their fertility is normal when the disease is quiescent, with the exception of women who have had pelvic surgery. IBD activity should be carefully monitored during pregnancy using non‐invasive techniques, and disease flares during pregnancy should be treated promptly with escalation of therapy in consultation with the patient's IBD specialist. Mode of delivery should be determined by obstetric need; however, caesarean delivery is preferred for women with a history of ileal pouch anal anastomosis surgery or active perianal Crohn's disease.Keywords
This publication has 51 references indexed in Scilit:
- Safety of TNF-α inhibitors during IBD pregnancy: a systematic reviewBMC Medicine, 2013
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2013
- Significantly Increased Pregnancy Rates After Laparoscopic Restorative ProctocolectomyAnnals of Surgery, 2012
- Patients' knowledge of pregnancy‐related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’)Alimentary Pharmacology & Therapeutics, 2012
- Corticosteroid use during pregnancy and risk of orofacial cleftsCanadian Medical Association Journal, 2011
- Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: A meta-analysisReproductive Toxicology, 2008
- Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Large Community-Based Study From Northern CaliforniaGastroenterology, 2007
- A meta-analysis on the influence of inflammatory bowel disease on pregnancyGut, 2006
- Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitisGut, 2006
- MALE INFERTILITY DUE TO SULPHASALAZINEThe Lancet, 1979